|
What is the local lung dose of smoke from emerging tobacco products? |
2019 (Cycle 30) |
$935,724 |
Environmental Exposure/Toxicology |
High Impact Research Project Award |
|
The Role of p53-Ninj2 loop in Tumor Progression and Metastasis |
2019 (Cycle 30) |
$492,239 |
Cancer |
High Impact Pilot Award |
|
Targeting aggressive kidney cancer cells deficient in a metabolic enzyme |
2019 (Cycle 29) |
$937,500 |
Cancer |
High Impact Research Project Award |
|
Mechanistic basis of arrhythmogenic cardiac alternans following tobacco smoke exposure |
2019 (Cycle 29) |
$500,000 |
Cardiovascular and Cerebrovascular Disease |
High Impact Pilot Award |
|
Mechanisms of Persistent Immune Dysregulation Following Early Life Tobacco Smoke Exposure |
2019 (Cycle 29) |
$85,841 |
Environmental Exposure/Toxicology |
Dissertation Awards |
|
Selectin-targeted glycocalyx mimetic as a treatment for pulmonary inflammation |
2019 (Cycle 29) |
$132,097 |
Pulmonary Disease |
Dissertation Awards |
|
Building Tobacco Cessation Connections Across Los Angeles Co |
2016 (Cycle 25) |
$387,222 |
Tobacco-Use Prevention and Cessation |
Community Practice-Based Research |
|
Targeting phospho-MARCKS in smoke-mediated lung cancer |
2014 (Cycle 23) |
$91,436 |
Early Diagnosis/Pathogenesis |
Postdoctoral Fellowship Awards |
|
Joint roles of ceramide, EGFR/Src in lung injury and cancer |
2013 (Cycle 22) |
$467,498 |
Early Diagnosis/Pathogenesis |
Research Project Awards |
|
Sacramento Taking Action Against Nicotine Dependence |
2013 (Cycle 22) |
$256,054 |
Disparities /Prevention/ Cessation/ Nicotine Dependence |
Pilot CARA |
|
Imaging SHS Deposition in the Airways of Sprague-Dawley Rats |
2012 (Cycle 21) |
$218,999 |
Environmental Exposure/Toxicology |
Exploratory/Developmental Award |
|
Integrated multi-omics approach to detect early lung cancer |
2011 (Cycle 20) |
$744,466 |
Cancer |
Integrated Research Project |
|
Epigenetic effects of cigarette smoke on the infant airway |
2011 (Cycle 20) |
$82,569 |
Pulmonary Disease |
Postdoctoral Fellowship Awards |
|
Cigarette smoke and lung injury: mechanism of nSMase2 action |
2011 (Cycle 20) |
$117,255 |
Pulmonary Disease |
Postdoctoral Fellowship Awards |
|
A Novel Anti-Cancer Therapy: Inhibition of MUS81-EME1 |
2011 (Cycle 20) |
$60,000 |
Cancer |
Dissertation Awards |
|
Novel treatments for COPD with Statins |
2009 (Cycle 18) |
$269,523 |
Pulmonary Disease |
New Investigator Awards |
|
Pro-inflammatory sPLA2, integrins, and smoking |
2009 (Cycle 18) |
$250,000 |
Cardiovascular Disease |
Exploratory/Developmental Award |
|
Expanding Los Angeles County eConsult Cessation Services |
2019 (Cycle 28) |
$1,748,266 |
Tobacco-Use Prevention and Cessation |
Community Practice-Based Research |
|
Therapeutic targeting to inhibit lung fibrosis progression |
2019 (Cycle 28) |
$925,286 |
Pulmonary Disease |
High Impact Research Project Award |
|
GLP-1 Hormone in Severe Asthma |
2019 (Cycle 28) |
$937,500 |
Pulmonary Disease |
High Impact Research Project Award |
|
E-cigarette vaping, chemical composition and lung toxicity |
2018 (Cycle 27) |
$910,493 |
Environmental Exposure/Toxicology |
High Impact Research Project Award |
|
Pulmonary Innate Lymphoid Cells and airway inflammation in COPD |
2018 (Cycle 27) |
$937,500 |
Pulmonary Disease |
High Impact Research Project Award |
|
Whole Genome RNAseq Studies of Blood in Smokers vs Nonsmokers |
2018 (Cycle 27) |
$400,000 |
Cardiovascular and Cerebrovascular Disease |
High Impact Pilot Award |
|
Studies on SWI/SNF in 3D chromatin structure with viral epis |
2018 (Cycle 27) |
$212,207 |
Cancer |
Postdoctoral Fellowship Awards |
|
Tackling Stem-Like Cells in Tobacco Smoke-Mediated Cancer Ma |
2018 (Cycle 27) |
$750,000 |
Cancer |
New Investigator Awards |
|
Development of the COPD Phenotype:Role of the IL-22/IL-22R1 Axis |
2017 (Cycle 26) |
$299,333 |
Pulmonary Disease |
High Impact Pilot Award |
|
Corepressors, TZDs, and tobacco-induced lung inflammation |
2009 (Cycle 18) |
$249,587 |
Pulmonary Disease |
Exploratory/Developmental Award |
|
Lung Development, Tobacco Smoke and Sensitivity to Infection |
2009 (Cycle 18) |
$280,000 |
Pulmonary Disease |
Exploratory/Developmental Award |
|
Cigarette smoke injures lung epithelium by activating nSMase |
2008 (Cycle 17) |
$394,380 |
Pulmonary Disease |
Research Project Awards |
|
Replication Recovery Through Recombination and Mus81-Mms4 |
2008 (Cycle 17) |
$60,000 |
General Biomedical Science |
Dissertation Awards |
|
Mechanisms of Tumor Suppressor in Lung Cancer Initiation |
2008 (Cycle 17) |
$75,000 |
Cancer |
Postdoctoral Fellowship Awards |
|
Oxylipin Mediators Prevent Smoke-Induced Lung Inflammation |
2007 (Cycle 16) |
$260,203 |
Pulmonary Disease |
New Investigator Awards |
|
Epigenetic Regulation of Airway MUC gene expression by smoke |
2007 (Cycle 16) |
$419,528 |
Pulmonary Disease |
Research Project Awards |
|
Mechanism of DNA break repair in germline cells |
2007 (Cycle 16) |
$75,000 |
Cancer |
Postdoctoral Fellowship Awards |
|
How smoke induces lung damage via oxidative stress |
2006 (Cycle 15) |
$75,000 |
Pulmonary Disease |
Postdoctoral Fellowship Awards |
|
Stem cell regeneration of the airway: effects of smoke |
2006 (Cycle 15) |
$269,443 |
Pulmonary Disease |
New Investigator Awards |
|
Tobacco, acculturation and gastric cancer among Hispanics |
2005 (Cycle 14) |
$179,367 |
Epidemiology |
New Investigator Awards |
|
Asthma, gender, and ETS: pathogenic synergy |
2005 (Cycle 14) |
$98,908 |
Pulmonary Disease |
Inno Dev & Exp Awards (IDEAS) |
|
Effect of smoke and gender on bronchiolar injury and repair |
2005 (Cycle 14) |
$418,207 |
Pulmonary Disease |
Research Project Awards |
|
SHS enhances cough via plasticity of brainstem neurons |
2004 (Cycle 13) |
$387,150 |
Pulmonary Disease |
Research Project Awards |
|
Regulation of a novel airway glandular mucin by smoke |
2004 (Cycle 13) |
$126,126 |
Pulmonary Disease |
New Investigator Awards |
|
Tobacco oxidants, EGF receptor stability, and lung disease |
2004 (Cycle 13) |
$75,000 |
Pulmonary Disease |
Postdoctoral Fellowship Awards |
|
Dietary fat and ETS effects on lung epithelial biology |
2003 (Cycle 12) |
$99,827 |
Pulmonary Disease |
Inno Dev & Exp Awards (IDEAS) |
|
Chemotherapeutic inhibition of polysialic acid biosynthesis |
2003 (Cycle 12) |
$420,781 |
Cancer |
Research Project Awards |
|
Irritant and analgesic effects of nicotine |
2002 (Cycle 11) |
$226,650 |
Nicotine Dependence |
Research Project Awards |
|
Effect of cigarette smoke and nicotine on taste processing |
2002 (Cycle 11) |
$70,000 |
Nicotine Dependence |
Postdoctoral Fellowship Awards |
|
Effect of smoke and gender on bronchiolar injury and repair |
2002 (Cycle 11) |
$413,288 |
Pulmonary Disease |
Research Project Awards |
|
Involvement of PI3K pathway in bladder cancer invasion |
2002 (Cycle 11) |
$224,984 |
Cancer |
New Investigator Awards |
|
Impact of Cultural Competence on Treatment Outcomes |
2002 (Cycle 11) |
$1,500 |
Tobacco-Use Prevention and Cessation |
Special Projects |
|
Effects of tobacco smoke on airway bactericidal activity |
2001 (Cycle 10) |
$87,079 |
Pulmonary Disease |
New Investigator Awards |
|
Effect of cigarette smoking on pulmonary metastasis |
2001 (Cycle 10) |
$36,236 |
Cancer |
Inno Dev & Exp Awards (IDEAS) |
|
Molecular targets for tobacco oxidants in lung cell death |
2001 (Cycle 10) |
$70,000 |
Pulmonary Disease |
Postdoctoral Fellowship Awards |
|
Mechanism of smoke-induced MUC5B gene expression |
2001 (Cycle 10) |
$392,117 |
Pulmonary Disease |
Research Project Awards |
|
Effects of nicotine on taste processing |
2001 (Cycle 10) |
$24,834 |
Nicotine Dependence |
Dissertation Awards |
|
Heat shock proteins as biomarkers of lung oxidant stress |
2000 (Cycle 9) |
$24,338 |
Pulmonary Disease |
Dissertation Awards |
|
Effect of estrogen on ETS-induced glyco-oxidation |
2000 (Cycle 9) |
$24,692 |
Cardiovascular Disease |
Dissertation Awards |
|
Thiol-aldehyde adducts and tobacco smoke toxicity |
2000 (Cycle 9) |
$49,622 |
Pulmonary Disease |
Postdoctoral Fellowship Awards |
|
Chronic bronchitis: pathology of mucin gene expression |
2000 (Cycle 9) |
$329,481 |
Pulmonary Disease |
Research Project Awards |
|
ETS effects on breathing patterns |
2000 (Cycle 9) |
$590,780 |
Pulmonary Disease |
Research Project Awards |
|
Modeling the relation of smoking to the ovarian function |
1999 (Cycle 8) |
$53,448 |
Epidemiology |
Dissertation Awards |
|
An RNA biomarker for tobacco smoke toxicity |
1999 (Cycle 8) |
$51,751 |
General Biomedical Science |
Dissertation Awards |
|
Tobacco oxidants and the ceramide path in lung cell death |
1999 (Cycle 8) |
$427,613 |
Pulmonary Disease |
Research Project Awards |
|
Effect of secondhand smoke on pulmonary t cell recruitment |
1999 (Cycle 8) |
$69,094 |
Pulmonary Disease |
Inno Dev & Exp Awards (IDEAS) |
|
Activation of NF-kB by cigarette smoke |
1999 (Cycle 8) |
$224,217 |
Pulmonary Disease |
New Investigator Awards |
|
Effect of tobacco smoke on nitric oxide synthesis |
1999 (Cycle 8) |
$70,000 |
Cardiovascular Disease |
Postdoctoral Fellowship Awards |
|
Carbon monoxide as a modulator of myocardial function |
1999 (Cycle 8) |
$225,000 |
Cardiovascular Disease |
New Investigator Awards |
|
Pathogenesis of Smoke-Induced Injury in Airway Epithelium |
1994 (Cycle 3) |
$431,266 |
Pulmonary Disease |
Research Project Awards |
|
Smoking and Arterial Flux of Low Density Lipoprotein |
1994 (Cycle 3) |
$274,674 |
Cardiovascular Disease |
Research Project Awards |
|
Na/H Exchange in Hypoxic/Ischemic Myocardium: Effects on Ca |
1994 (Cycle 3) |
$243,322 |
Cardiovascular Disease |
Research Project Awards |
|
Desensitization of Cholinergic Mechanisms & Nicotine Addiction |
1994 (Cycle 3) |
$267,178 |
Nicotine Dependence |
Research Project Awards |
|
Environmental Tobacco Smoke and Fetal Growth Retardation |
1994 (Cycle 3) |
$124,865 |
General Biomedical Science |
Research Project Awards |
|
Environmental Tobacco Smoke and Lung Cancer |
1994 (Cycle 3) |
$234,432 |
Cancer |
Research Project Awards |
|
Environmental Tobacco Smoke & Epithelial Barrier Function |
1994 (Cycle 3) |
$221,949 |
Pulmonary Disease |
New Investigator Awards |
|
Endothelial Barrier Injury by Tobacco Smoke |
1994 (Cycle 3) |
$225,000 |
Cardiovascular Disease |
New Investigator Awards |
|
Animal Models of Human Risk from Environmental Tobacco Smoke |
1994 (Cycle 3) |
$135,482 |
Epidemiology |
New Investigator Awards |
|
Angiotensin II and Restenosis after Coronary Angioplasty |
1993 (Cycle 2) |
$228,018 |
Cardiovascular Disease |
Research Project Awards |
|
Effect of Cigarette Smoke on Vascular Wall Permeability |
1993 (Cycle 2) |
$99,854 |
Cardiovascular Disease |
Research Project Awards |
|
Tumor Specific Antibodies |
1993 (Cycle 2) |
$224,974 |
Cancer |
New Investigator Awards |
|
Effects of Environmental Tobacco Smoke on Pulmonary Allergy |
1993 (Cycle 2) |
$62,512 |
Pulmonary Disease |
Inno Dev & Exp Awards (IDEAS) |
|
Smoking & Atherosclerosis--An Autoimmune Phenomenon? |
1992 (Cycle 1) |
$151,149 |
Cardiovascular Disease |
Research Project Awards |
|
Smoking Effects on Maternal Folate & Reproductive Outcomes |
1992 (Cycle 1) |
$105,988 |
Epidemiology |
Research Project Awards |
|
Smoking & Adverse Reproductive Health Effects in Women |
1992 (Cycle 1) |
$550,243 |
Epidemiology |
Research Project Awards |
|
Tobacco Smoke: Mechanistic Roles in COPD |
1992 (Cycle 1) |
$250,297 |
Pulmonary Disease |
Research Project Awards |
|
Passive Smoking & Clara Cell Developement in the Lungs |
1992 (Cycle 1) |
$435,023 |
Pulmonary Disease |
Research Project Awards |
|
Pathogenesis of Cigarette Smoke-Induced Bronchitis |
1992 (Cycle 1) |
$487,719 |
Pulmonary Disease |
Research Project Awards |
|
Nicotine, Hypertension & Induction of Aortic Disease |
1992 (Cycle 1) |
$182,010 |
Cardiovascular Disease |
Research Project Awards |
|
CNS Processing of Lung Afferent & Cigarette Smoke Inputs |
1992 (Cycle 1) |
$261,726 |
Pulmonary Disease |
Research Project Awards |
|
Lung Cancer Associated Retinopathy |
1992 (Cycle 1) |
$352,945 |
Cancer |
Research Project Awards |
|
Adenosine Airway Reactivity & Receptors in Smokers |
1992 (Cycle 1) |
$93,500 |
Pulmonary Disease |
Research Project Awards |
|
Sidestream Smoke Effects on Immature Airway Receptors |
1992 (Cycle 1) |
$211,744 |
Pulmonary Disease |
New Investigator Awards |
|
Nicotine & Cardiavascular Control During Exercise |
1992 (Cycle 1) |
$220,302 |
Cardiovascular Disease |
New Investigator Awards |
|
Cigarette Smoke Induced Changes in Gene Expression |
1992 (Cycle 1) |
$222,046 |
Cancer |
New Investigator Awards |
|
Lung Reflexes & Afferent Properties in Health and Disease |
1992 (Cycle 1) |
$70,000 |
Pulmonary Disease |
Postdoctoral Fellowship Awards |
|
Analysis of RAS Mutations in the Canine Smoking Model |
1992 (Cycle 1) |
$70,000 |
Cancer |
Postdoctoral Fellowship Awards |
|
Nicotine Effects on Enodthelial Cell Growth & Function |
1992 (Cycle 1) |
$69,038 |
Cardiovascular Disease |
Postdoctoral Fellowship Awards |
|
Pulmonary Epithelial Injury by Tobacco Smoke in Vitro |
1992 (Cycle 1) |
$70,616 |
Pulmonary Disease |
Postdoctoral Fellowship Awards |
|
Molecular Studies of NNK-Induced Lung Tumors in Hamsters |
1992 (Cycle 1) |
$35,000 |
Cancer |
Postdoctoral Fellowship Awards |
|
Endothelial Barrier Injury by Tobacco Smoke |
1992 (Cycle 1) |
$60,945 |
Cardiovascular Disease |
Postdoctoral Fellowship Awards |
|
Nitrogen Oxides and cigarette smoke-induced injury |
1998 (Cycle 7) |
$304,118 |
Pulmonary Disease |
Research Project Awards |
|
Vitamin E kinetics in smokers |
1998 (Cycle 7) |
$332,110 |
General Biomedical Science |
Research Project Awards |
|
Role of thioredoxin in ETS-induced pulmonary airway injury |
1998 (Cycle 7) |
$425,665 |
Pulmonary Disease |
Research Project Awards |
|
ETS Effects on airway development in the primate lung |
1998 (Cycle 7) |
$483,652 |
General Biomedical Science |
Research Project Awards |
|
Effects of environmental tobacco smoke on pulmonary allergy |
1998 (Cycle 7) |
$282,568 |
Pulmonary Disease |
Research Project Awards |
|
Smoking and lifestyle risk factors for premenstrual changes |
1998 (Cycle 7) |
$297,783 |
Epidemiology |
Research Project Awards |
|
Effects of environmental tobacco smoke on the artery wall |
1998 (Cycle 7) |
$449,673 |
Cardiovascular Disease |
Research Project Awards |
|
Environmental tobacco smoke and newborn lung development |
1997 (Cycle 6) |
$440,500 |
General Biomedical Science |
Research Project Awards |
|
Secondhand smoke promotes chemical toxicity in fetal lung |
1997 (Cycle 6) |
$190,536 |
General Biomedical Science |
Research Project Awards |
|
Irritant and pain-reducing effects of nicotine |
1997 (Cycle 6) |
$415,704 |
Nicotine Dependence |
Research Project Awards |
|
ETS effects on pulmonary breathing patterns |
1997 (Cycle 6) |
$446,954 |
Pulmonary Disease |
Research Project Awards |
|
Effects of tobacco on inflammatory cell responses |
1997 (Cycle 6) |
$223,585 |
Pulmonary Disease |
New Investigator Awards |
|
Effect of sidestream smoke on lung injury and repair |
1997 (Cycle 6) |
$214,070 |
Pulmonary Disease |
New Investigator Awards |
|
Alterations in gene expression after tobacco smoke exposure |
1997 (Cycle 6) |
$216,612 |
Pulmonary Disease |
New Investigator Awards |
|
NMR Study of 13C Edatrexate Metabolism |
1995 (Cycle 4) |
$258,990 |
Cancer |
Research Project Awards |
|
Effects of Environmental Tobacco Smoke on Pulmonary Allergy |
1995 (Cycle 4) |
$256,805 |
Pulmonary Disease |
Research Project Awards |
|
Passive Smoking and Clara Cell Development in the Lungs |
1995 (Cycle 4) |
$442,317 |
Pulmonary Disease |
Research Project Awards |
|
Gene Augmentation Therapy for Tobacco Induced Emphysema |
1995 (Cycle 4) |
$224,786 |
Pulmonary Disease |
New Investigator Awards |
|
Irritant & Analgesic Effects of Nicotine |
1995 (Cycle 4) |
$75,000 |
General Biomedical Science |
Inno Dev & Exp Awards (IDEAS) |
|
p53 Mutations in Sporadic & Familial Childhood Tumors |
1994 (Cycle 3) |
$213,407 |
Cancer |
New Investigator Awards |